title: In reply to Robins et al.
authors.forename: Paul W
authors.initials: PW
authors.lastname: Sperduto
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000628:therapy*; D002289:Carcinoma, Non-Small-Cell Lung / Q000628:therapy*; D016371:Cranial Irradiation / Q000379:methods*; D003606:Dacarbazine / Q000031:analogs & derivatives*; D006801:Humans; D008175:Lung Neoplasms; D011799:Quinazolines / Q000627:therapeutic use*; D016634:Radiosurgery / Q000379:methods*
chemical_list: D000970:Antineoplastic Agents; D011799:Quinazolines; D003606:Dacarbazine